Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Investment Conference May 2, 2023

April 27, 2023

https://www.globenewswire.com/news-release/2023/04/27/2656265/27423/en/Galectin-Therapeutics-to-Participate-in-the-H-C-Wainwright-BioConnect-Investment-Conference-May-2-2023.html

NORCROSS, Ga., April 27, 2023 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company will be participating in the H.C. Wainwright BioConnect Investment Conference on Tuesday, May 2, 2023.

Read more at globenewswire.com

Related news for (GALT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.